Clinical trials would need to include more diverse groups of people to ensure treatments work for everyone.
This bill would require clinical trials for drugs, devices, and treatments to set clear goals for including people of different races, ethnicities, ages, and sexes. It aims to make sure new medical treatments are tested on a wide range of people, so they are safe and effective for everyone. The bill would also make it easier for people to participate in trials. It would launch a national campaign to raise awareness about diverse clinical trials.
Today, clinical trials may not always include enough diverse participants, which can mean new treatments aren't fully tested for everyone. After this bill, clinical trials would be required to set specific diversity goals for race, ethnicity, age, and sex, and offer easier ways for people to participate. There would also be a national effort to educate the public and healthcare professionals about the importance of diverse clinical trials.
HR 6867 · 119th Congress · December 18, 2025 · AI Summary by gemini-2.5-flash · 10/10
Sign in to see your representatives' phone numbers
1 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.